ATRX and central nervous system cancer: Intriguingly, the increased cellular motility and astrocytic histiogenic profile induced by Atrx deficiency in this in vitro model recapitulate two of the hallmark features associated with diffuse astrocytoma, the predominant ATRX-mutant human glioma subtype30.